Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time

摘要: Background Widespread application of left ventricular assist devices (LVADs) in advanced heart failure, is limited by costs, and access to technical expertise. Hospitalisation drives both cost inversely, quality life − but cross institutional pre-surgical inpatient length stay data missing the Australian literature. We describe changes hospitalisation rates, year before after bridge transplant LVAD therapy preceding (HTX). Methods Hospitalisation, refined diagnosis group (ArDRG), clinical were assessed for 77/100 consecutive patients listed between July 2009 June 2012. Twenty-five required device (VAD) whilst waitlisted. was defined as proportion "days at risk" that spent hospital included all public private admissions identified VAD implant, or HTX, a linked administrative dataset across New South Wales. Results Patients requiring VADs clinically more unstable proportionally time than pre-HTX patients, (13% (IQR 10-20%) vs 4% (IQR1-10%), p The number per patient reduced VAD-implant two (IQR1-3), from five pre-implant 3-7) p=0.002. This similar group's three (IQR1-6), p=0.33. Overall decreased beyond first 14% one-year 0.5% 0-10%) two-years (p=0.002). A high percentage prior (41%) HTX (66%) occurred outside centre. Conclusions activity occurs implanting with higher reflecting severity. Ventricular implantation significantly associated admissions, once reconditioning has occurred.